Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.87 +0.07 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Accounts Payables (2020 - 2026)

Updated

Unicycive Therapeutics (UNCY) posted Accounts Payables of $2.23 million for Q2 2026, up 188.3% from $775,000 a year earlier and up 96.0% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Accounts Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, Unicycive Therapeutics' Accounts Payables came in at $383,000, down 63.8% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
  • In prior years, Unicycive Therapeutics' Accounts Payables was $1.06 million in FY2024 (-47.1%), $2 million in FY2023 (+124.2%), $892,000 in FY2022 (+20.2%) and $742,000 in FY2021 (+303.3%).
  • The Q2 2026 figure stands as the highest quarterly Accounts Payables since Q3 2022.
  • On a year-over-year basis, Accounts Payables increased in three of the last eight quarters, with growth averaging 6.2%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2021, with growth of 303.3%; the weakest was Q4 2025, with a decline of 63.8%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $1.14 million (Q1 2026), $383,000 (Q4 2025) and $957,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 9.22 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.58 Bn
10 Unicycive Therapeutics 104.17 Mn -95.81 Mn - 2.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.23 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 383,000.00
Sep 30, 2025 957,000.00
Jun 30, 2025 775,000.00
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.06 Mn
Sep 30, 2024 548,000.00
Jun 30, 2024 1.47 Mn
Mar 31, 2024 1.24 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 1.08 Mn
Jun 30, 2023 503,000.00
Mar 31, 2023 790,000.00
Dec 31, 2022 892,000.00
Sep 30, 2022 2.29 Mn
Jun 30, 2022 747,000.00
Mar 31, 2022 589,000.00
Dec 31, 2021 742,000.00
Sep 30, 2021 49,000.00
API Access

Unicycive Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=UNCY&period=max&api_key=YOUR_API_KEY